周三盘中，麦斯莫医疗（Masimo Corp，股票代码：MASI）股价大幅下跌11.09%，引发投资者关注。这一显著跌幅似乎与多家华尔街分析机构下调该公司股票目标价有关。
据悉，杰富瑞证券将麦斯莫医疗的目标价从175美元下调至158美元，BTIG将目标价从206美元下调至193美元。与此同时，富国银行也将目标价从205美元下调至190美元，雷蒙德詹姆斯则将目标价从204美元下调至185美元。这些知名分析机构的一致看跌态度可能是导致投资者信心受挫的主要原因。
值得注意的是，尽管分析师普遍下调了麦斯莫医疗的目标价，但目前尚未有关于公司基本面发生重大变化的报道。投资者可能需要密切关注公司未来的财报表现和业务发展，以评估这次股价调整是否反映了公司的长期价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.